To view Track names, descriptions, objectives and target audience, click here.

Sessions scheduled on Wednesday, April 27 at 1:15, 2:30 and 3:45 are for RCM CLIENTS ONLY

SCM and other clients are not eligible to attend these sessions and will be participating in the Vendor Fair at this time.

*Accreditations appearing on this website are pending approval by the appropriate crediting agencies. Although MedAssets does not anticipate any denials, pleae check the signage outside the session room for final approvals.


Wilmington,  DE 
United States
  • Booth: 933

"AstraZeneca Research and Development AstraZeneca is a global biopharmaceutical company intent on the discovery, development, and commercialization of differentiated, value-adding prescription medicines. Our R&D efforts are focussed on four key therapeutic areas: Cardiovascular and Metabolic Diseases Oncology Respiratory, Inflammation and Autoimmunity Neuroscience"